RRx-001-Mediated Cardiopulmonary
As a nitric oxide (NO) donor under hypoxia and an NLRP3 inhibitor, RRx-001 protects/mitigates against several cardiopulmonary diseases including doxorubicin-induced congestive heart failure, pulmonary hypertension, acute myocardial infarction, stroke, ischemia reperfusion injury, and hypercholesterolemia and hypertriglyceridemia.
As a nitric oxide (NO) donor under hypoxia and an NLRP3 inhibitor, RRx-001 protects/mitigates against several cardiopulmonary diseases including doxorubicin-induced congestive heart failure, pulmonary hypertension, acute myocardial infarction, stroke, ischemia reperfusion injury, and hypercholesterolemia and hypertriglyceridemia.